Genetic-targeted therapy of thyroid cancer: a real promise.
Xing
Mingzhao
M
D045744:Cell Line, Tumor; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D020935:MAP Kinase Signaling System; D008495:Medical Oncology / Q000379:methods; D009154:Mutation; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism; D048493:Proto-Oncogene Proteins B-raf / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D013964:Thyroid Neoplasms / Q000235:genetics* / Q000628:therapy*; D018631:ras Proteins / Q000378:metabolism
D004791:Enzyme Inhibitors; D019869:Phosphatidylinositol 3-Kinases; C482119:BRAF protein, human; D048493:Proto-Oncogene Proteins B-raf; D051057:Proto-Oncogene Proteins c-akt; D018631:ras Proteins